3nww: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3nww.png|left|200px]] | |||
[[Image:3nww. | |||
{{STRUCTURE_3nww| PDB=3nww | SCENE= }} | {{STRUCTURE_3nww| PDB=3nww | SCENE= }} | ||
===P38 Alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitor=== | ===P38 Alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitor=== | ||
{{ABSTRACT_PUBMED_20732813}} | {{ABSTRACT_PUBMED_20732813}} | ||
==About this Structure== | ==About this Structure== | ||
[[3nww]] is a 1 chain structure of [[Mitogen-activated protein kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NWW OCA]. | |||
==See Also== | |||
*[[Mitogen-activated protein kinase|Mitogen-activated protein kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:020732813</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Mitogen-activated protein kinase]] | [[Category: Mitogen-activated protein kinase]] | ||
| Line 31: | Line 22: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
[[Category: Transferase-transferase inhibitor complex]] | [[Category: Transferase-transferase inhibitor complex]] | ||
Revision as of 07:07, 27 July 2012
P38 Alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitor
Template:ABSTRACT PUBMED 20732813
About this Structure
3nww is a 1 chain structure of Mitogen-activated protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Lin S, Wrobleski ST, Hynes J Jr, Pitt S, Zhang R, Fan Y, Doweyko AM, Kish KF, Sack JS, Malley MF, Kiefer SE, Newitt JA, McKinnon M, Trzaskos J, Barrish JC, Dodd JH, Schieven GL, Leftheris K. Utilization of a nitrogen-sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38alpha MAP kinase inhibitors. Bioorg Med Chem Lett. 2010 Jul 30. PMID:20732813 doi:10.1016/j.bmcl.2010.07.102